APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multi-disease Fundus Imaging-assisted Diagnostic System

Compare research editions
View pricing & licenses

Selected research

Industry Research

Multi-disease Fundus Imaging-assisted Diagnostic System Industry Research Report 2026

12 August 2026130 pages

Choose your research edition.

Industry ResearchMulti-disease Fundus Imaging-assisted Diagnostic System Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Multi-disease Fundus Imaging-assisted Diagnostic System Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Multi-disease Fundus Imaging-assisted Diagnostic System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multi-disease Fundus Imaging-assisted Diagnostic System Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Multi-disease Fundus Imaging-assisted Diagnostic System Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Multi-disease Fundus Imaging-assisted Diagnostic System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Multi-disease Fundus Imaging-assisted Diagnostic System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Multi-disease Fundus Imaging-assisted Diagnostic System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Multi-disease Fundus Imaging-assisted Diagnostic System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Multi-disease Fundus Imaging-assisted Diagnostic System include Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Intelligent Retinal Imaging Systems, Retmarker, CSIRO, WeDoctor Group and VoxelCloud, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Multi-disease Fundus Imaging-assisted Diagnostic System market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Multi-disease Fundus Imaging-assisted Diagnostic System.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Multi-disease Fundus Imaging-assisted Diagnostic System Market by Company

Remidio

RetinAI

RetinaRisk

Eyenuk, Inc.

Intelligent Retinal Imaging Systems

Retmarker

CSIRO

WeDoctor Group

VoxelCloud

Zhenhealth

Tencent Health

Airdoc

Silicon Intelligence

Zhiyuan Huitu

Kangfuzi Health

AEYE Health

RetinaLyze

DeepMind

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Type

On-premise

Cloud-based

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Application

Hospitals

Clinics

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-disease Fundus Imaging-assisted Diagnostic System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multi-disease Fundus Imaging-assisted Diagnostic System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-disease Fundus Imaging-assisted Diagnostic System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Multi-disease Fundus Imaging-assisted Diagnostic System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Type (2021-2026) Table 7. Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Type (2027-2032) Table 9. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Application (2021-2026) Table 11. Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Application (2027-2032) Table 13. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region (2021-2026) Table 16. Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region (2027-2032) Table 18. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Trends Table 19. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Drivers Table 20. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Opportunities and Challenges Table 21. Multi-disease Fundus Imaging-assisted Diagnostic System Market Restraints Table 22. Global Top Multi-disease Fundus Imaging-assisted Diagnostic System Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Players (2021-2026) Table 24. Global Multi-disease Fundus Imaging-assisted Diagnostic System Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System, Headquarters and Area Served Table 26. Global Multi-disease Fundus Imaging-assisted Diagnostic System Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Multi-disease Fundus Imaging-assisted Diagnostic System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032) & (US$ Million) Table 45. Remidio Company Information Table 46. Remidio Business Overview Table 47. Remidio Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 48. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 49. Remidio Recent Developments Table 50. RetinAI Company Information Table 51. RetinAI Business Overview Table 52. RetinAI Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 53. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 54. RetinAI Recent Developments Table 55. RetinaRisk Company Information Table 56. RetinaRisk Business Overview Table 57. RetinaRisk Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 58. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 59. RetinaRisk Recent Developments Table 60. Eyenuk, Inc. Company Information Table 61. Eyenuk, Inc. Business Overview Table 62. Eyenuk, Inc. Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 63. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 64. Eyenuk, Inc. Recent Developments Table 65. Intelligent Retinal Imaging Systems Company Information Table 66. Intelligent Retinal Imaging Systems Business Overview Table 67. Intelligent Retinal Imaging Systems Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 68. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 69. Intelligent Retinal Imaging Systems Recent Developments Table 70. Retmarker Company Information Table 71. Retmarker Business Overview Table 72. Retmarker Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 73. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 74. Retmarker Recent Developments Table 75. CSIRO Company Information Table 76. CSIRO Business Overview Table 77. CSIRO Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 78. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 79. CSIRO Recent Developments Table 80. WeDoctor Group Company Information Table 81. WeDoctor Group Business Overview Table 82. WeDoctor Group Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 83. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 84. WeDoctor Group Recent Developments Table 85. VoxelCloud Company Information Table 86. VoxelCloud Business Overview Table 87. VoxelCloud Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 88. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 89. VoxelCloud Recent Developments Table 90. Zhenhealth Company Information Table 91. Zhenhealth Business Overview Table 92. Zhenhealth Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 93. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 94. Zhenhealth Recent Developments Table 95. Tencent Health Company Information Table 96. Tencent Health Business Overview Table 97. Tencent Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 98. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 99. Tencent Health Recent Developments Table 100. Airdoc Company Information Table 101. Airdoc Business Overview Table 102. Airdoc Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 103. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 104. Airdoc Recent Developments Table 105. Silicon Intelligence Company Information Table 106. Silicon Intelligence Business Overview Table 107. Silicon Intelligence Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 108. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 109. Silicon Intelligence Recent Developments Table 110. Zhiyuan Huitu Company Information Table 111. Zhiyuan Huitu Business Overview Table 112. Zhiyuan Huitu Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 113. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 114. Zhiyuan Huitu Recent Developments Table 115. Kangfuzi Health Company Information Table 116. Kangfuzi Health Business Overview Table 117. Kangfuzi Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 118. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 119. Kangfuzi Health Recent Developments Table 120. AEYE Health Company Information Table 121. AEYE Health Business Overview Table 122. AEYE Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 123. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 124. AEYE Health Recent Developments Table 125. RetinaLyze Company Information Table 126. RetinaLyze Business Overview Table 127. RetinaLyze Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 128. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 129. RetinaLyze Recent Developments Table 130. DeepMind Company Information Table 131. DeepMind Business Overview Table 132. DeepMind Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) & (US$ Million) Table 133. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 134. DeepMind Recent Developments Table 135. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Multi-disease Fundus Imaging-assisted Diagnostic System Product Image Figure 5. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Type: 2025 VS 2032 Figure 7. On-premise Product Figure 8. Cloud-based Product Figure 9. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Product Figure 12. Clinics Product Figure 13. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 14. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region: 2025 VS 2032 Figure 16. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Players in 2025 Figure 17. Global Multi-disease Fundus Imaging-assisted Diagnostic System Manufacturers Established Date Figure 18. Global Top 5 and 10 Multi-disease Fundus Imaging-assisted Diagnostic System Players Market Share by Revenue in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 21. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 22. United States Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. Canada Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 25. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 27. Germany Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. France Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. U.K. Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Italy Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Spain Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Russia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Netherlands Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Nordic Countries Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 37. China Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Japan Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. India Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 42. Australia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. China Taiwan Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 47. Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Chile Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Colombia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Peru Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Remidio Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 53. RetinAI Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 54. RetinaRisk Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 55. Eyenuk, Inc. Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 56. Intelligent Retinal Imaging Systems Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 57. Retmarker Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 58. CSIRO Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 59. WeDoctor Group Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 60. VoxelCloud Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 61. Zhenhealth Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 62. Tencent Health Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 63. Airdoc Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 64. Silicon Intelligence Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 65. Zhiyuan Huitu Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 66. Kangfuzi Health Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 67. AEYE Health Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 68. RetinaLyze Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026) Figure 69. DeepMind Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)

Scope & coverage.

Types
  • On-premise
  • Cloud-based
Applications
  • Hospitals
  • Clinics
Companies covered
  • Remidio
  • RetinAI
  • RetinaRisk
  • Eyenuk, Inc.
  • Intelligent Retinal Imaging Systems
  • Retmarker
  • CSIRO
  • WeDoctor Group
  • VoxelCloud
  • Zhenhealth
  • Tencent Health
  • Airdoc
  • Silicon Intelligence
  • Zhiyuan Huitu
  • Kangfuzi Health
  • AEYE Health
  • RetinaLyze
  • DeepMind

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Multi-disease Fundus Imaging-assisted Diagnostic System by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 On-premise
  5. 2.2.3 Cloud-based
  6. 2.3 Multi-disease Fundus Imaging-assisted Diagnostic System by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Hospitals
  9. 2.3.3 Clinics
  10. 2.4 Assumptions and Limitations
3 Multi-disease Fundus Imaging-assisted Diagnostic System Breakdown Data by Type
  1. 3.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Historic Market Size by Type (2021-2026)
  2. 3.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Type (2027-2032)
4 Multi-disease Fundus Imaging-assisted Diagnostic System Breakdown Data by Application
  1. 4.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Historic Market Size by Application (2021-2026)
  2. 4.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Perspective (2021-2032)
  2. 5.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Growth Trends by Region
  3. 5.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Multi-disease Fundus Imaging-assisted Diagnostic System Historic Market Size by Region (2021-2026)
  5. 5.2.3 Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Region (2027-2032)
  6. 5.3 Multi-disease Fundus Imaging-assisted Diagnostic System Market Dynamics
  7. 5.3.1 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Trends
  8. 5.3.2 Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers
  9. 5.3.3 Multi-disease Fundus Imaging-assisted Diagnostic System Market Challenges
  10. 5.3.4 Multi-disease Fundus Imaging-assisted Diagnostic System Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Multi-disease Fundus Imaging-assisted Diagnostic System Players by Revenue
  2. 6.1.1 Global Top Multi-disease Fundus Imaging-assisted Diagnostic System Players by Revenue (2021-2026)
  3. 6.1.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System Head Office and Area Served
  6. 6.4 Global Multi-disease Fundus Imaging-assisted Diagnostic System Players, Product Type & Application
  7. 6.5 Global Multi-disease Fundus Imaging-assisted Diagnostic System Manufacturers Established Date
  8. 6.6 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032)
  2. 7.2 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  4. 7.4 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032)
  2. 8.2 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  4. 8.4 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032)
  2. 9.2 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032)
  2. 10.2 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  4. 10.4 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032)
  2. 11.2 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Remidio
  2. 12.1.1 Remidio Company Information
  3. 12.1.2 Remidio Business Overview
  4. 12.1.3 Remidio Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  5. 12.1.4 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  6. 12.1.5 Remidio Recent Developments
  7. 12.2 RetinAI
  8. 12.2.1 RetinAI Company Information
  9. 12.2.2 RetinAI Business Overview
  10. 12.2.3 RetinAI Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  11. 12.2.4 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  12. 12.2.5 RetinAI Recent Developments
  13. 12.3 RetinaRisk
  14. 12.3.1 RetinaRisk Company Information
  15. 12.3.2 RetinaRisk Business Overview
  16. 12.3.3 RetinaRisk Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  17. 12.3.4 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  18. 12.3.5 RetinaRisk Recent Developments
  19. 12.4 Eyenuk, Inc.
  20. 12.4.1 Eyenuk, Inc. Company Information
  21. 12.4.2 Eyenuk, Inc. Business Overview
  22. 12.4.3 Eyenuk, Inc. Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  23. 12.4.4 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  24. 12.4.5 Eyenuk, Inc. Recent Developments
  25. 12.5 Intelligent Retinal Imaging Systems
  26. 12.5.1 Intelligent Retinal Imaging Systems Company Information
  27. 12.5.2 Intelligent Retinal Imaging Systems Business Overview
  28. 12.5.3 Intelligent Retinal Imaging Systems Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  29. 12.5.4 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  30. 12.5.5 Intelligent Retinal Imaging Systems Recent Developments
  31. 12.6 Retmarker
  32. 12.6.1 Retmarker Company Information
  33. 12.6.2 Retmarker Business Overview
  34. 12.6.3 Retmarker Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  35. 12.6.4 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  36. 12.6.5 Retmarker Recent Developments
  37. 12.7 CSIRO
  38. 12.7.1 CSIRO Company Information
  39. 12.7.2 CSIRO Business Overview
  40. 12.7.3 CSIRO Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  41. 12.7.4 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  42. 12.7.5 CSIRO Recent Developments
  43. 12.8 WeDoctor Group
  44. 12.8.1 WeDoctor Group Company Information
  45. 12.8.2 WeDoctor Group Business Overview
  46. 12.8.3 WeDoctor Group Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  47. 12.8.4 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  48. 12.8.5 WeDoctor Group Recent Developments
  49. 12.9 VoxelCloud
  50. 12.9.1 VoxelCloud Company Information
  51. 12.9.2 VoxelCloud Business Overview
  52. 12.9.3 VoxelCloud Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  53. 12.9.4 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  54. 12.9.5 VoxelCloud Recent Developments
  55. 12.10 Zhenhealth
  56. 12.10.1 Zhenhealth Company Information
  57. 12.10.2 Zhenhealth Business Overview
  58. 12.10.3 Zhenhealth Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  59. 12.10.4 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  60. 12.10.5 Zhenhealth Recent Developments
  61. 12.11 Tencent Health
  62. 12.11.1 Tencent Health Company Information
  63. 12.11.2 Tencent Health Business Overview
  64. 12.11.3 Tencent Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  65. 12.11.4 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  66. 12.11.5 Tencent Health Recent Developments
  67. 12.12 Airdoc
  68. 12.12.1 Airdoc Company Information
  69. 12.12.2 Airdoc Business Overview
  70. 12.12.3 Airdoc Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  71. 12.12.4 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  72. 12.12.5 Airdoc Recent Developments
  73. 12.13 Silicon Intelligence
  74. 12.13.1 Silicon Intelligence Company Information
  75. 12.13.2 Silicon Intelligence Business Overview
  76. 12.13.3 Silicon Intelligence Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  77. 12.13.4 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  78. 12.13.5 Silicon Intelligence Recent Developments
  79. 12.14 Zhiyuan Huitu
  80. 12.14.1 Zhiyuan Huitu Company Information
  81. 12.14.2 Zhiyuan Huitu Business Overview
  82. 12.14.3 Zhiyuan Huitu Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  83. 12.14.4 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  84. 12.14.5 Zhiyuan Huitu Recent Developments
  85. 12.15 Kangfuzi Health
  86. 12.15.1 Kangfuzi Health Company Information
  87. 12.15.2 Kangfuzi Health Business Overview
  88. 12.15.3 Kangfuzi Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  89. 12.15.4 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  90. 12.15.5 Kangfuzi Health Recent Developments
  91. 12.16 AEYE Health
  92. 12.16.1 AEYE Health Company Information
  93. 12.16.2 AEYE Health Business Overview
  94. 12.16.3 AEYE Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  95. 12.16.4 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  96. 12.16.5 AEYE Health Recent Developments
  97. 12.17 RetinaLyze
  98. 12.17.1 RetinaLyze Company Information
  99. 12.17.2 RetinaLyze Business Overview
  100. 12.17.3 RetinaLyze Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  101. 12.17.4 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  102. 12.17.5 RetinaLyze Recent Developments
  103. 12.18 DeepMind
  104. 12.18.1 DeepMind Company Information
  105. 12.18.2 DeepMind Business Overview
  106. 12.18.3 DeepMind Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021-2026)
  107. 12.18.4 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  108. 12.18.5 DeepMind Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst